FDA — authorised 21 April 2014
- Marketing authorisation holder: ELI LILLY AND CO
- Status: approved
🇺🇸 Cyramza in United States
FDA authorised Cyramza on 21 April 2014
Marketing authorisations
FDA — authorised 21 April 2014
- Application: BLA125477
- Marketing authorisation holder: ELI LILLY AND CO
- Local brand name: CYRAMZA
- Indication: INJECTABLE — INJECTION
- Status: approved
Cyramza in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Oncology approved in United States
Frequently asked questions
Is Cyramza approved in United States?
Yes. FDA authorised it on 21 April 2014; FDA authorised it on 21 April 2014.
Who is the marketing authorisation holder for Cyramza in United States?
ELI LILLY AND CO holds the US marketing authorisation.